3.9 Article

Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: A nationwide population-based cohort study

期刊

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
卷 42, 期 11-12, 页码 917-923

出版社

INFORMA HEALTHCARE
DOI: 10.3109/00365548.2010.511258

关键词

-

资金

  1. Region Hovedstaden
  2. Hvidovre Hospital's
  3. Thora og Viggo Grove's Mindelegat
  4. Christian Larsen og dommer Ellen Larsens Legat
  5. University of Copenhagen and Rigshospitalet
  6. Roche
  7. Bristol-Myers Squibb
  8. Merck Sharp Dohme
  9. GlaxoSmithKline
  10. Abbott
  11. Boehringer Ingelheim
  12. Janssen-Cilag
  13. Swedish Orphan

向作者/读者索取更多资源

The objective of this study was to determine the effect of highly active antiretroviral therapy (HAART) in human immunodeficiency virus (HIV)-infected patients infected through injecting drug use (injecting drug users, IDUs) compared to patients infected via other routes (non-IDUs). We conducted a nationwide population-based cohort study of all HIV-infected patients who initiated HAART during the study period of 1 January 1995 to 31 December 2007. We compared changes in CD4

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.9
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据